FDA Warns Public Against Fake Paracetamol Tablets
MANILA, Philippines — The Food and Drug Administration (FDA) has issued a warning to the public and healthcare professionals about the circulation of counterfeit paracetamol tablets.
In an advisory signed by FDA Director General Samuel Zacate, the agency provided images of a fake paracetamol (Biogesic®) 500 mg tablet. The counterfeit version displayed discrepancies in lot number, capsule design, knurling, and print appearance compared to the authentic product.
Public Advisory
The FDA emphasized the importance of purchasing medications only from FDA-licensed establishments to avoid health risks associated with counterfeit drugs. The agency also cautioned all establishments against selling fake medicines, noting that they will face legal consequences if found guilty.
"The importation, sale, and distribution of these counterfeit products violate Republic Act No. 9711 or the Food and Drug Administration Act of 2009, and Republic Act No. 8203 or the Special Law on Counterfeit Drugs. Anyone found selling these fake products will be punished," the advisory stated.
Call for Vigilance
The FDA called on local government units and law enforcement agencies to ensure that these counterfeit products are not sold or used within their jurisdictions. The agency's proactive measures aim to protect public health and ensure the integrity of pharmaceutical products available in the market.
This advisory serves as a crucial reminder for the public to remain vigilant and prioritize their health by purchasing medications from authorized sources only.
Comments
Post a Comment